GlassScriptPhysician profile
Caitlin E Fulton
NPI 1093120594
$734.82
in general payments reported to CMS, 2019-2025
16 companies · $218 in 2025
The $218 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16.91 · 2022: $188 · 2023: $104 · 2024: $208 · 2025: $218.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $530.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $530.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $177.96 | 2024-2025 | Jakafi, Monjuvi, Zynyz |
| Pfizer INC. | $84.44 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $68.20 | 2022-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $58.59 | 2022-2023 | Ninlaro |
| Genentech USA, INC. | $53.77 | 2024-2025 | Polivy, Lunsumio, Columvi |
| Amgen INC. | $52.90 | 2022 | |
| Ipsen Biopharmaceuticals, INC | $47.72 | 2022 | |
| Merck Sharp & Dohme LLC | $29.49 | 2024 | Lynparza, Keytruda |
| Progenics Pharmaceuticals, INC. | $25.35 | 2023 | Pylarify |
| Syndax Pharmaceuticals, INC. | $24.62 | 2025 | |
| Eisai INC. | $24.01 | 2023 | |
| Emd Serono, INC. | $18.90 | 2023 | Tepmetko |
| Adc Therapeutics America, INC. | $18.19 | 2024 | |
| Rigel Pharmaceuticals, INC. | $17.48 | 2024 | Rezlidhia, Tavalisse |
| Janssen Biotech, INC. | $17.38 | 2024 | Tecvayli, Talvey |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $15.82 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caitlin Fulton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.